It has been revealed that FATP5 participated in PI3K/AKT signaling pathway (Liu et al., 2019), Cyclin-dependent protein serine/threonine kinase regulator activity and p53 signaling pathway (Liu et al., 2020), indicating FATP5 acted as a significant part to cell cycle in CRC. This evidence concerns the gene SLC27A5 and colorectal carcinoma.